First Genetic Disease Screening Kit For Consumers Gets FDA Approval
Graphic by Angelie Zaslavsky
23andMe, the genetic testing service co-founded by Anne Wojcicki, has won landmark approval to administer tests for risk of developing 10 hereditary illnesses. In a new ruling, the Food and Drug Administration reversed its 2013 decision to deny the company approval.
Included among the conditions it screens are Parkinson’s Disease, Alzheimer’s Disease, celiac disease and Gaucher Disease –- a rare ailment suffered mostly by Ashkenazi Jews, which results in bone and joint pain, spleen issues and potential neurological damage.
23andMe offers a package in which consumers provide a DNA sample to the company and for $199 get a report breaking down their ethnic ancestry and risk for a host of diseases.
Vox notes that this makes it “the first company to sell regulator-approved genetic predisposition tests directly to consumers.”
FDA officials, while approving the company’s plans, warned that genetic testing is not the final word on whether a person will develop a given illness. “It is important that people understand that genetic risk is just one piece of the bigger puzzle, it does not mean they will or won’t ultimately develop a disease,” Jeffrey Shuren, head of the agency’s Center for Devices and Radiological Health, wrote in a statement.
Contact Daniel J. Solomon at [email protected] or on Twitter @DanielJSolomon
This is a moment of great uncertainty. Here’s what you can do about it.
We hope you appreciated this article. Before you go, we’d like to ask you to please support the Forward’s independent Jewish news this Passover. All donations are being matched by the Forward Board - up to $100,000.
This is a moment of great uncertainty for the news media, for the Jewish people, and for our sacred democracy. It is a time of confusion and declining trust in public institutions. An era in which we need humans to report facts, conduct investigations that hold power to account, tell stories that matter and share honest discourse on all that divides us.
With no paywall or subscriptions, the Forward is entirely supported by readers like you. Every dollar you give this Passover is invested in the future of the Forward — and telling the American Jewish story fully and fairly.
The Forward doesn’t rely on funding from institutions like governments or your local Jewish federation. There are thousands of readers like you who give us $18 or $36 or $100 each month or year.
Support our mission to tell the Jewish story fully and fairly.
